seed
Stage
1
Investors
About
Slatebio develops advanced regulatory T cell (T reg) therapies to treat autoimmune diseases.
Explore Slatebio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.
Slatebio develops advanced regulatory T cell (T reg) therapies to treat autoimmune diseases.
Funding rounds, investor list, and risk signals — unlock with a subscription.